Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides

Anti-cancer Drugs
Tadao FunatoM Kaku

Abstract

c-raf-1, a cytoplasmic serine/threonine protein kinase, plays an important role in mitogen- and damage-responsive cellular signal transduction pathways. Expression of c-raf-1 modifies cell growth, proliferation and survival. Although expression of c-raf-1 has been studied in several tumors, the role of c-raf-1 in leukemia is so far unclear. We examined the expression of c-raf-1 in the human leukemia cell lines U937 and K562, and in a cytosine arabinoside (Ara-C)-resistant cell line (K562AC) derived from K562. Expression of c-raf-1 was increased in U937 and in Ara-C-resistant K562AC cells compared with the parental cells. We then investigated whether inhibition of c-raf-1 expression by antisense oligonucleotides increases the sensitivity to Ara-C in U937 and K562AC cells. Antisense oligonucleotides for c-raf-1 inhibited expression of c-raf-1 mRNA, but did not affect cell growth and increased sensitivity to Ara-C but not to other drugs such as adriamycin, VP-16 or vincristine. These results suggest that c-raf-1 is one of the factors involved in Ara-C resistance in leukemia and lend weight to the case for development of anti-cancer therapeutics involving oncogene-targeted antisense oligonucleotides.

References

Jan 1, 1990·Critical Reviews in Oncology/hematology·J C Willey, C C Harris
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K J ScanlonD G Priest
Mar 1, 1994·Cancer Metastasis Reviews·N G Williams, T M Roberts
Jun 4, 1999·Antisense & Nucleic Acid Drug Development·P C GokhaleU Kasid
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P StevensonP J O'Dwyer
Mar 31, 2000·Experimental Cell Research·T G CrossJ M Lord
Apr 27, 2000·Leukemia Research·T FunatoT Sasaki

❮ Previous
Next ❯

Citations

Apr 16, 2003·Gynecologic Oncology·A M OzaUNKNOWN NCIC Clinical Trials Group Study (NCIC IND.116)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.